CN104322443A - Chicken raising method of laying hens - Google Patents
Chicken raising method of laying hens Download PDFInfo
- Publication number
- CN104322443A CN104322443A CN201410572016.XA CN201410572016A CN104322443A CN 104322443 A CN104322443 A CN 104322443A CN 201410572016 A CN201410572016 A CN 201410572016A CN 104322443 A CN104322443 A CN 104322443A
- Authority
- CN
- China
- Prior art keywords
- laying
- chinese medical
- medical extract
- water
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 31
- 241000287828 Gallus gallus Species 0.000 title abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 39
- 239000000843 powder Substances 0.000 claims abstract description 19
- 241000756943 Codonopsis Species 0.000 claims abstract description 18
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 17
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims abstract description 17
- 235000017491 Bambusa tulda Nutrition 0.000 claims abstract description 17
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 17
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 17
- 241000218691 Cupressaceae Species 0.000 claims abstract description 17
- 241000123069 Ocyurus chrysurus Species 0.000 claims abstract description 17
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims abstract description 17
- 241000736246 Pyrola Species 0.000 claims abstract description 17
- 241000270708 Testudinidae Species 0.000 claims abstract description 17
- 239000011425 bamboo Substances 0.000 claims abstract description 17
- 244000068988 Glycine max Species 0.000 claims abstract description 15
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 15
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 11
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 11
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims abstract description 11
- 235000015921 sodium selenite Nutrition 0.000 claims abstract description 11
- 239000011781 sodium selenite Substances 0.000 claims abstract description 11
- 229960001471 sodium selenite Drugs 0.000 claims abstract description 11
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 11
- 239000011710 vitamin D Substances 0.000 claims abstract description 11
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 11
- 229940046008 vitamin d Drugs 0.000 claims abstract description 11
- 229940036811 bone meal Drugs 0.000 claims abstract description 10
- 239000002374 bone meal Substances 0.000 claims abstract description 10
- 244000082204 Phyllostachys viridis Species 0.000 claims abstract 4
- 239000000284 extract Substances 0.000 claims description 99
- 239000003651 drinking water Substances 0.000 claims description 27
- 235000020188 drinking water Nutrition 0.000 claims description 27
- 238000004519 manufacturing process Methods 0.000 claims description 21
- 150000001413 amino acids Chemical class 0.000 claims description 20
- 244000307697 Agrimonia eupatoria Species 0.000 claims description 16
- 241000005787 Cistanche Species 0.000 claims description 16
- 240000006766 Cornus mas Species 0.000 claims description 16
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 16
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 16
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 16
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 16
- 240000005001 Paeonia suffruticosa Species 0.000 claims description 16
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- 235000000125 common agrimony Nutrition 0.000 claims description 16
- 239000011780 sodium chloride Substances 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 15
- 235000005911 diet Nutrition 0.000 claims description 9
- 235000012054 meals Nutrition 0.000 claims description 9
- 230000037213 diet Effects 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 6
- 238000002386 leaching Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 102000002322 Egg Proteins Human genes 0.000 abstract description 35
- 108010000912 Egg Proteins Proteins 0.000 abstract description 35
- 210000003278 egg shell Anatomy 0.000 abstract description 35
- 239000003814 drug Substances 0.000 abstract description 23
- 210000004994 reproductive system Anatomy 0.000 abstract description 17
- 230000035622 drinking Effects 0.000 abstract 3
- 241001278836 Agrimonia pilosa Species 0.000 abstract 1
- 235000000641 Agrimonia pilosa Nutrition 0.000 abstract 1
- 241000336315 Cistanche salsa Species 0.000 abstract 1
- 241000209020 Cornus Species 0.000 abstract 1
- 235000015512 Liquidambar formosana Nutrition 0.000 abstract 1
- 241000893545 Liquidambar formosana Species 0.000 abstract 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract 1
- 244000144977 poultry Species 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 235000013601 eggs Nutrition 0.000 description 68
- 239000008280 blood Substances 0.000 description 14
- 241001330002 Bambuseae Species 0.000 description 13
- 210000001672 ovary Anatomy 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 12
- 230000035611 feeding Effects 0.000 description 12
- 230000001076 estrogenic effect Effects 0.000 description 10
- 239000005556 hormone Substances 0.000 description 10
- 229940088597 hormone Drugs 0.000 description 10
- 229940079593 drug Drugs 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 230000017448 oviposition Effects 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 6
- 238000007689 inspection Methods 0.000 description 6
- 239000002932 luster Substances 0.000 description 6
- 230000005906 menstruation Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000002611 ovarian Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 210000000981 epithelium Anatomy 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 210000003101 oviduct Anatomy 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 230000002085 persistent effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- AZJQQNWSSLCLJN-UHFFFAOYSA-N 2-ethoxyquinoline Chemical compound C1=CC=CC2=NC(OCC)=CC=C21 AZJQQNWSSLCLJN-UHFFFAOYSA-N 0.000 description 2
- ZCFFYALKHPIRKJ-UHFFFAOYSA-N 3-[18-(2-carboxylatoethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-21,24-diium-2-yl]propanoate Chemical compound N1C(C=C2C(=C(C)C(=CC=3C(C)=C(CCC(O)=O)C(N=3)=C3)N2)C=C)=C(C)C(C=C)=C1C=C1C(C)=C(CCC(O)=O)C3=N1 ZCFFYALKHPIRKJ-UHFFFAOYSA-N 0.000 description 2
- 108010011619 6-Phytase Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 230000001919 adrenal effect Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000001165 anti-coccidial effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 230000003185 calcium uptake Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229940085127 phytase Drugs 0.000 description 2
- 239000000049 pigment Chemical group 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000017443 reproductive system disease Diseases 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 235000009529 zinc sulphate Nutrition 0.000 description 2
- 239000011686 zinc sulphate Substances 0.000 description 2
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 1
- 235000003092 Artemisia dracunculus Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241001016310 Epimedium grandiflorum Species 0.000 description 1
- 108010060374 FSH Receptors Proteins 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 102000018343 Follicle stimulating hormone receptors Human genes 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 240000002817 Leonurus sibiricus Species 0.000 description 1
- 235000002434 Leonurus sibiricus Nutrition 0.000 description 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000010359 Newcastle Disease Diseases 0.000 description 1
- UKHWDRMMMYWSFL-UHFFFAOYSA-N Nicarbazin Chemical compound CC=1C=C(C)NC(=O)N=1.C1=CC([N+](=O)[O-])=CC=C1NC(=O)NC1=CC=C([N+]([O-])=O)C=C1 UKHWDRMMMYWSFL-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- TURHTASYUMWZCC-UHFFFAOYSA-N Olaquindox [BAN:INN] Chemical compound C1=CC=C2N([O-])C(C)=C(C(=O)NCCO)[N+](=O)C2=C1 TURHTASYUMWZCC-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 244000226566 Psoralea corylifolia Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000736078 Schisandra sphenanthera Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- VVYPIVJZLVJPGU-UHFFFAOYSA-L copper;2-aminoacetate Chemical compound [Cu+2].NCC([O-])=O.NCC([O-])=O VVYPIVJZLVJPGU-UHFFFAOYSA-L 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229940011405 cupric glycinate Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000018905 epimedium Nutrition 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229960001614 levamisole Drugs 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 208000004141 microcephaly Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229940073485 nicarbazin Drugs 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 229950010210 olaquindox Drugs 0.000 description 1
- 229940055705 pangamic acid Drugs 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002955 secretory cell Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides a chicken raising method of laying hens. The method comprises the following steps that A laying hen laying beginning period: Chinese medicine extractive drinking is supplied, and water is added to dilute the Chinese medicine extractive with the mass percent being 0.5-1%, B laying hen laying high yield period: the Chinese medicine extractive drinking is supplied, and the water is added to dilute the Chinese medicine extractive with the mass percent being 1-2%, C laying hen laying post period: the Chinese medicine extractive drinking is supplied, and the water is added to dilute the Chinese medicine extractive with the mass percent being 2-4%, the Chinese medicine extractive 3-5% is added in feed daily ration, the content of bone meal or shell powder is increased to 4.8-5.2%, sodium selenite 0.001-0.002% is added, the content of vitamin D is increased to 0.01-0.05%, the components of the Chinese medicine extractive are 60-80g of bamboo leaves, golden cypress and cortex moutan, 40-60g of liquidambar formosana hance, honeysuckle, malt, madder, agrimonia pilosa, safflower, semen ziziphi spinosae and pyrola, 30-50g of yam, cistanche salsa, radix codonopsis, cornus and tortoise shell and 20-25g of soybean. The method is simple and convenient to use, the poultry reproductive system is promoted to grow, the reproductive system is stable in function, the laying period is prolonged, the egg shell quality is kept, and the egg shell is prevented from being light.
Description
technical field:
The present invention relates to chicken fowl cultural technique field, particularly relate to the chicken-raising method of a kind of laying hen.
background technology:
In Egg Production of Laying Hens process, bird inlay is in ovipository cycle, and body weight, egg size and egg production all have the change of certain regularity, according to these changes, laying period can be divided into three sections: lay eggs early stage, egg-laying peak and lay eggs the later stage.Modern layer breed, general 18 ~ 19 week age saw egg, and 23 ~ 25 week age, laying rate reached 50%; 27 ~ 29 week age entered egg-laying peak (laying rate is greater than 90%), and the highest laying rate can reach more than 95%.Egg-laying peak generally sustainable about 20 weeks.After 54 week age, laying rate is lower than 80%, and the latter stage laying rate of laying eggs still can reach 50% to 70%.In whole laying period, especially the later stage can find the phenomenon that egg has eggshell color to shoal, and the egg of this color, is not esthetically acceptable to the consumers, and can cause the greater loss of raiser.Analyze the reason that eggshell shoals:
Oviduct pathology: analyze according to investigations, most brown shell eggshell look shoals, and to mass-send raw disease with chicken relevant.When after pathogen invasion chicken body, can directly occur or secondary causes genital tract pathological change in various degree, there is oedema, hyperemia or hemorrhage in oviduct, causes necrosis time serious, mucous epithelium comes off, and eggshell body of gland is synthesized and secretes calcium and pigment function part or complete gold to lose.The most serious disease of harm has that newcastle disease, egg-decreasing syndrome, biography are propped up, white diarrhea, bird flu etc.Because of serious infringement genital system, fall sharply except causing laying rate, eggshell thinning, to increase without shell egg except, and to fade the comparatively typical clinical symptoms such as to shoal, bleach with eggshell.Prove that this kind of disease has genital system pathology.Genital system generation pathology, ovary can not be brought into normal play function, and especially uterine tubal epithelium secretory cell is abnormal, even if ovary can be ovulated, is also difficult to the structure forming normal egg.
Drug administration:
There is report, take Nicarbazin anticoccidial, these pigments of synthesis can be disturbed, cause normally producing brown shell egg product kind chicken and produce white shell egg.Throw when chicken in egg-laying period prophylactic treatment regular incidence or mixed infection and to take medicine thing, as sulfamido, olaquindox, anticoccidial drug or anthelmintic, service time or consumption improper, be formed with harmful effect also to egg.Such as open term and peak period prohibits the use Using Levamisole To Eliminate Parasites, to feed to sulfa drugs, in order to avoid suppress the formation of the activity of carbonic anhydrase and normal ooporphyrin not for a long time.
Other factors:
According to the selective examination of laying eggs to certain anosis chicken group, eggshell look is also had to shoal or with the egg of brown spot.The egg of most lighter, major part is painted heavy and microcephaly is painted shallow, and also with the feature of eggshell thinning, egg face is coarse, bright in strip.Measure through getting multiple spot eggshell fragments, thick average 336 μm of normal coloured eggshell, average 294 μm of the eggshell that shoals, obviously than the egg of normal look more thinning.Spot egg has the stigma of diffusivity needle point size or the block spot of 1 ~ 2mm, and shell look shoals also by various factors.Some data introductions, (opening term) shell look of laying eggs the initial stage is comparatively dark, and high term, color was medium, and the later stage of laying eggs shoals, and this should fail relevant with the Reproductive Performance in later stage laying period.
In general, ooporphyrin is formed and has nothing to do with certain nutrient deficiency, but remote-effects exist.The squamous cornified epithelium that such as, oviduct normal mucosa epithelium can be caused to be layered when VA lacks replaced, thus causes malfunction.Have scholar to think, slightly stress or the chicken egg appearance of producing of short time agitation cover extra calcium, and produce not exhilarating eggshell color.Other foreign scholars also find to be off color normal, deformity and other Abnormal Eggs incidence obviously with egg Formation period stress be relevant, have also demonstrated the impact of environmental factor on eggshell structure and eggshell color.
But, in above-mentioned impact, the change of the genital system of laying hen and drug administration improper be major effect, for this technical problem, there are some solutions for this problem.Disclosed in " Animal nutrition journal " 2009 " energy is on the impact of laying hen ovary follicle-stimulating hormone Receptor mRNA and laying rate " find, dietary digestibility of energy may affect mrna expression to sexually matured effect and then affect the growth of folliculus ovarii relevant, suitable energy level can improve mrna expression, and the expression of the ovary mRNA in 22 week age of laying hen can become the indication index of producing thereafter courage height.As Chinese patent application 201110187047X discloses a kind of novel fodder additive, additive is by vitamin A, vitamin D, vitamin E, zinc sulphate, dihydropyridine, poplar bark lipoid, ethoxyquinoline or dibutyl hydroxy toluene, starch is made by proportioning, this feed addictive, by improving the environment of laying hen body, regulate estrogen secretion, promote growing and Regeneration and Repair of ovary tissue, improve the productivity of laying hen, remarkable result is had to the bird after high age in days egg-laying bird and disease cured, can retrieve and again hatch, the loss of brought time and the economy of brooding.And for example Chinese patent application 2013100196188 discloses a kind of compound premix promoting laying hen build and the development of ovary, and the component of compound premix and weight portion are: B B-complex 0.2-0.6, composite trace element 1.5-3.0, compound Chinese herb 1-3, oil powder 8-10, Choline Chloride 1-2, methionine 4-5, lysine 2-4, threonine 3-5, calcium monohydrogen phosphate 18-22, stone flour 20-30, salt 5-6, probiotic 2-4, phytase 0.1-0.4, bean cake powder 5-34.2; Useful total viable count >=2 × the 108CFU/g of described probiotic, described phytase activity is 5000U/g; The composition of B B-complex every kilogram containing following weight: vitamin A 42000000IU, vitamine D3 10000000IU, vitamin E 33600000IU, Vitamin K3 4800mg, pangamic acid 500mg, vitamin B2 16000mg, calcium pantothenate 43000mg, nicotinic acid 86000mg, cobalamin 18000mg, vitamin h 5500mg, folic acid 1900mg, antioxidant 500mg, in described antioxidant, the weight percentage of active ingredient ethoxyquinoline is 10%; The composition of composite trace element every kilogram containing following weight: copper sulphate 4.4g, 15% cupric glycinate 6.7 grams, zinc sulphate 26.8g, 15% glycine zine 53 grams, manganese sulphate 62.8g, 10% Mn-Gly 150 grams, ferrous sulfate 39.7g, 20% ferrous glycine 50 grams, sodium selenite 3g; The composition of compound Chinese herb every kilogram containing following weight: barrenwort 60 grams, 24 grams, Fructus Hordei Germinatus, Psoralea corylifolia 36 grams, siberian motherwort 60 grams, tarragon 36 grams, the Radix Astragali 36 grams, Radix Codonopsis 24 grams, the fruit of glossy privet 60 grams, Schisandra sphenanthera Rehd.et WilS 36 grams.Can promote that laying hen grows and Development of Reproductive System, improve laying hen build, strengthen disease-resistant anti-stress ability, for laying period, the raising of productivity is laid a good foundation.
The present invention on the basis of existing technology, aims to provide a kind of method simple, easy to use, promotes chicken fowl Development of Reproductive System, maintains genital system function-stable, extend laying period, keep egg quality of egg, the chicken-raising method of laying hen.
summary of the invention:
The object of the invention is to overcome the shortcoming existed in prior art, provide a kind of method simple, easy to use, promote chicken fowl Development of Reproductive System, maintain genital system function-stable, extend laying period, keep egg quality of egg, the chicken-raising method of laying hen.
For achieving the above object, the invention discloses the chicken-raising method of a kind of laying hen, wherein,
A, Egg Production of Laying Hens open term: supply Chinese medical extract drinking-water, and Chinese medical extract is diluted with water to mass percent 0.5-1%;
B, Egg Production of Laying Hens height term: supply Chinese medical extract drinking-water, Chinese medical extract is diluted with water to mass percent 1-2%;
C, laying cycle of laying hens later stage: supply Chinese medical extract drinking-water, Chinese medical extract is diluted with water to mass percent 2-4%; Meanwhile, add Chinese medical extract 3-5% in feed diet, improve the content of bone meal or conch meal to 4.8-5.2%, add sodium selenite 0.001-0.002%, the content of vitamin D increases to 0.01-0.05%.
The component of described Chinese medical extract is:
The leaf of bamboo, golden cypress, each 60-80g of the root bark of tree peony, play both sides of the street, honeysuckle, Fructus Hordei Germinatus, madder, hairyvein agrimony, safflower, spina date seed, each 40-60g of pyrola, Chinese yam, saline cistanche, Radix Codonopsis, dogwood, each 30-50g of tortoise plastron, soybean 20-25g.
Or the component of described Chinese medical extract is:
The leaf of bamboo, golden cypress, each 60-70g of the root bark of tree peony, play both sides of the street, honeysuckle, Fructus Hordei Germinatus, madder, hairyvein agrimony, safflower, spina date seed, each 40-50g of pyrola, Chinese yam, saline cistanche, Radix Codonopsis, dogwood, each 30-40g of tortoise plastron, soybean 20-22g.
Or the component of described Chinese medical extract is:
The leaf of bamboo, golden cypress, each 70-80g of the root bark of tree peony, play both sides of the street, honeysuckle, Fructus Hordei Germinatus, madder, hairyvein agrimony, safflower, spina date seed, each 50-60g of pyrola, Chinese yam, saline cistanche, Radix Codonopsis, dogwood, each 40-50g of tortoise plastron, soybean 22-25g.
Time prepared by Chinese medical extract:
After said components is mixed, with water extract method lixiviate three times, after three times leaching liquor merges, boiling obtains mixture of viscous form, adds CMC and flavouring; The mass ratio of CMC, flavouring is 2:1, the quality of CMC and flavouring and be the 2-3% of mixture of viscous form quality, pulvis is obtained after drying, pulvis is after ultraviolet irradiation is sterilized 10 seconds, add amino acid powder, the quality of the amino acid powder added is the 0.01-0.03% of pulvis quality, obtains Chinese medical extract after mixing.
The inventive method is simple, easy to use, promotes chicken fowl Development of Reproductive System, maintains genital system function-stable, extend laying period, keep egg quality of egg, avoid eggshell to shoal, the mechanism of action of Chinese medical extract of the present invention:
Ovary outer as adipose tissue, adrenal virtueization enzyme system also can release portion oestrogenic hormone, therefore, by medicine (particularly Chinese medicine), ovary is failed or oestrogenic hormone minimizing recovery is orderly or slow down decline rate.
The present invention, plays both sides of the street for monarch drug in a prescription with the leaf of bamboo, golden cypress, the root bark of tree peony, honeysuckle, Fructus Hordei Germinatus, madder, hairyvein agrimony, safflower, spina date seed, pyrola are ministerial drug, and Chinese yam, saline cistanche, Radix Codonopsis, dogwood, tortoise plastron are adjutant, and soybean is for making medicine.
Leaf of bamboo clearing heat and relieving fidgetness, promote the production of body fluid, diuresis, golden cypress heat-clearing and damp-drying drug, purging intense heat and detonicating, root bark of tree peony promoting blood circulation to remove blood stasis, play both sides of the street dispelling, collateral-activating, Li Shui, stimulate the menstrual flow, honeysuckle dispelling wind and heat from the body, its active ingredient cyanidenon stimulates oestrogenic hormone, Fructus Hordei Germinatus help digestion and in, madder activating blood to promote menstruation, hairyvein agrimony astringing to arrest bleeding, qi-restoratives, safflower activating blood to promote menstruation, spina date seed nourishes heart beneficial liver, calm the nerves, pyrola strengthening the bones and muscles, regulating menstruation, hemostasis, Chinese yam supplementing qi and nourishing yin, tonifying spleen lung kidney, saline cistanche benefiting essence-blood, relax bowel, Radix Codonopsis tonifying middle-Jiao and Qi, promote the production of body fluid, nourish blood, dogwood tonifies the liver and kidney, tortoise plastron consolidating channel for hemostasis, to nourish blood bushing, daizeol stimulates oestrogenic hormone.The present invention is to improve immunity of organisms simultaneously, and tonify the liver and kidney stimulation oestrogenic hormone, promotes hematopoiesis function, maintains the better state of genital system, and filling liver kidney, nourishing blood and invigorating qi reduce genital system diseases and then ensure eggshell color and luster.The amino acid powder added is commercially available prod, and index is total number of bacteria 5000/g, Escherichia coli: 30MPN/100g total amino acid content 80.9, essential amino acid/total amino acid content 36.1.Appropriate protein (makeup energy maintains ovarian function) is supplemented by amino acid powder.Later stage increases bone meal or conch meal, improves the calcium content of feed, strengthens calcium uptake by vitamin D, keeps eggshell hardness, adds in feed
sodium selenite, laying rate, incubation rate and young incubation rate can be improved to bird.
embodiment:
The chicken-raising method of laying hen:
A, Egg Production of Laying Hens open term: supply Chinese medical extract drinking-water, and Chinese medical extract is diluted with water to mass percent 0.5-1%;
B, Egg Production of Laying Hens height term: supply Chinese medical extract drinking-water, Chinese medical extract is diluted with water to mass percent 1-2%;
C, laying cycle of laying hens later stage: supply Chinese medical extract drinking-water, Chinese medical extract is diluted with water to mass percent 2-4%; Meanwhile, add Chinese medical extract 3-5% in feed diet, improve the content of bone meal or conch meal to 4.8-5.2%, add sodium selenite 0.001-0.002%, the content of vitamin D increases to 0.01-0.05%.
The component of described Chinese medical extract is:
The leaf of bamboo, golden cypress, each 60-80g of the root bark of tree peony, play both sides of the street, honeysuckle, Fructus Hordei Germinatus, madder, hairyvein agrimony, safflower, spina date seed, each 40-60g of pyrola, Chinese yam, saline cistanche, Radix Codonopsis, dogwood, each 30-50g of tortoise plastron, soybean 20-25g.
Or the component of described Chinese medical extract is:
The leaf of bamboo, golden cypress, each 60-70g of the root bark of tree peony, play both sides of the street, honeysuckle, Fructus Hordei Germinatus, madder, hairyvein agrimony, safflower, spina date seed, each 40-50g of pyrola, Chinese yam, saline cistanche, Radix Codonopsis, dogwood, each 30-40g of tortoise plastron, soybean 20-22g.
Or the component of described Chinese medical extract is:
The leaf of bamboo, golden cypress, each 70-80g of the root bark of tree peony, play both sides of the street, honeysuckle, Fructus Hordei Germinatus, madder, hairyvein agrimony, safflower, spina date seed, each 50-60g of pyrola, Chinese yam, saline cistanche, Radix Codonopsis, dogwood, each 40-50g of tortoise plastron, soybean 22-25g.
Time prepared by Chinese medical extract:
After said components is mixed, with water extract method lixiviate three times, after three times leaching liquor merges, boiling obtains mixture of viscous form, adds CMC and flavouring; The mass ratio of CMC, flavouring is 2:1, the quality of CMC and flavouring and be the 2-3% of mixture of viscous form quality, pulvis is obtained after drying, pulvis is after ultraviolet irradiation is sterilized 10 seconds, add amino acid powder, the quality of the amino acid powder added is the 0.01-0.03% of pulvis quality, obtains Chinese medical extract after mixing.
Object lesson 1
A raiser 6000 laying hens are opened in Jiangzhou, make to cultivate with the following method:
A, Egg Production of Laying Hens open term: supply Chinese medical extract drinking-water, and Chinese medical extract is diluted with water to mass percent 0.5-1%;
B, Egg Production of Laying Hens height term: supply Chinese medical extract drinking-water, Chinese medical extract is diluted with water to mass percent 1-2%;
C, laying cycle of laying hens later stage: supply Chinese medical extract drinking-water, Chinese medical extract is diluted with water to mass percent 2-4%; Meanwhile, add Chinese medical extract 3% in feed diet, improve the content to 4.8% of bone meal or conch meal, add sodium selenite 0.001%, the content of vitamin D increases to 0.01%.
The component of described Chinese medical extract is:
The leaf of bamboo, golden cypress, each 80g of the root bark of tree peony, play both sides of the street, honeysuckle, Fructus Hordei Germinatus, madder, hairyvein agrimony, safflower, spina date seed, each 60g of pyrola, Chinese yam, saline cistanche, Radix Codonopsis, dogwood, each 50g of tortoise plastron, soybean 25g.
Time prepared by Chinese medical extract:
After said components is mixed, with water extract method lixiviate three times, after three times leaching liquor merges, boiling obtains mixture of viscous form, adds CMC and flavouring; The mass ratio of CMC, flavouring is 2:1, the quality of CMC and flavouring and be 2% of mixture of viscous form quality, pulvis is obtained after drying, pulvis is after ultraviolet irradiation is sterilized 10 seconds, add amino acid powder, the quality of the amino acid powder added is 0.01% of pulvis quality, obtains Chinese medical extract after mixing.
19 weeks start to see egg, supply Chinese medical extract drinking-water, and Chinese medical extract is diluted with water to mass percent 0.6%; Within 22 weeks, namely laying rate reaches 50%, within 25 weeks, enters high term (laying rate is greater than 90%), supply Chinese medical extract drinking-water, and Chinese medical extract is diluted with water to mass percent 1%; Within 28 weeks, reach 96-100%, the 26 weeks persistent levels time of laying eggs of 28 weeks, 70% enter latter stage of laying eggs during 54 week age when 88%, 56 weeks when 85%, 66 weeks, supply Chinese medical extract drinking-water, Chinese medical extract is diluted with water to mass percent 2.5%; Lay eggs and continue 4 weeks latter stage (higher than 50%, lower than 70%.), after 50%, enter and eliminate or moult program.
In whole laying period, eggshell deliquescing lower than 0.022%, eggshell color and luster shoal lower than 0.031%.
Object lesson 2
Field auspicious ecologic breeding 10000 laying hen, makes with the following method
A, Egg Production of Laying Hens open term: supply Chinese medical extract drinking-water, and Chinese medical extract is diluted with water to mass percent 0.5-1%;
B, Egg Production of Laying Hens height term: supply Chinese medical extract drinking-water, Chinese medical extract is diluted with water to mass percent 1-2%;
C, laying cycle of laying hens later stage: supply Chinese medical extract drinking-water, Chinese medical extract is diluted with water to mass percent 2-4%; Meanwhile, add Chinese medical extract 4% in feed diet, improve the content to 5.0% of bone meal or conch meal, add sodium selenite 0.002%, the content of vitamin D increases to 0.02%.
The component of described Chinese medical extract is:
The leaf of bamboo, golden cypress, each 60g of the root bark of tree peony, play both sides of the street, honeysuckle, Fructus Hordei Germinatus, madder, hairyvein agrimony, safflower, spina date seed, each 40g of pyrola, Chinese yam, saline cistanche, Radix Codonopsis, dogwood, each 30g of tortoise plastron, soybean 20g.
Time prepared by Chinese medical extract:
After said components is mixed, with water extract method lixiviate three times, after three times leaching liquor merges, boiling obtains mixture of viscous form, adds CMC and flavouring; The mass ratio of CMC, flavouring is 2:1, the quality of CMC and flavouring and be the 2-3% of mixture of viscous form quality, pulvis is obtained after drying, pulvis is after ultraviolet irradiation is sterilized 10 seconds, add amino acid powder, the quality of the amino acid powder added is 0.02% of pulvis quality, obtains Chinese medical extract after mixing.
19 weeks start to see egg, supply Chinese medical extract drinking-water, and Chinese medical extract is diluted with water to mass percent 0.8%; Within 21 weeks, namely laying rate reaches 50%, within 24 weeks, enters high term (laying rate is greater than 90%), supply Chinese medical extract drinking-water, and Chinese medical extract is diluted with water to mass percent 1.5%; Within 28 weeks, reach 96-100%, the 27 weeks persistent levels time of laying eggs of 28 weeks, 70% enter latter stage of laying eggs during 58 week age when 88%, 58 weeks when 85%, 67 weeks, supply Chinese medical extract drinking-water, Chinese medical extract is diluted with water to mass percent 3%; Lay eggs and continue 4 weeks latter stage (higher than 50%, lower than 70%.), after 50%, enter and eliminate or moult program.
In whole laying period, eggshell deliquescing lower than 0.025%, eggshell color and luster shoal lower than 0.028%.
Example 3
Jimo Mao San village Mao Shi raiser, cultivates 4000 laying hens.
A, Egg Production of Laying Hens open term: supply Chinese medical extract drinking-water, and Chinese medical extract is diluted with water to mass percent 0.5-1%;
B, Egg Production of Laying Hens height term: supply Chinese medical extract drinking-water, Chinese medical extract is diluted with water to mass percent 1-2%;
C, laying cycle of laying hens later stage: supply Chinese medical extract drinking-water, Chinese medical extract is diluted with water to mass percent 2-4%; Meanwhile, add Chinese medical extract 3-5% in feed diet, improve the content of bone meal or conch meal to 4.8-5.2%, add sodium selenite 0.002%, the content of vitamin D increases to 0.04%.
The component of described Chinese medical extract is:
The leaf of bamboo, golden cypress, each 70g of the root bark of tree peony, play both sides of the street, honeysuckle, Fructus Hordei Germinatus, madder, hairyvein agrimony, safflower, spina date seed, each 50g of pyrola, Chinese yam, saline cistanche, Radix Codonopsis, dogwood, each 40g of tortoise plastron, soybean 22g.
Time prepared by Chinese medical extract:
After said components is mixed, with water extract method lixiviate three times, after three times leaching liquor merges, boiling obtains mixture of viscous form, adds CMC and flavouring; The mass ratio of CMC, flavouring is 2:1, the quality of CMC and flavouring and be 3% of mixture of viscous form quality, pulvis is obtained after drying, pulvis is after ultraviolet irradiation is sterilized 10 seconds, add amino acid powder, the quality of the amino acid powder added is 0.03% of pulvis quality, obtains Chinese medical extract after mixing.
19 weeks start to see egg, supply Chinese medical extract drinking-water, and Chinese medical extract is diluted with water to mass percent 1%; Within 21 weeks, namely laying rate reaches 50%, within 24 weeks, enters high term (laying rate is greater than 90%), supply Chinese medical extract drinking-water, and Chinese medical extract is diluted with water to mass percent 2%; Within 27 weeks, reach 96-100%, the 27 weeks persistent levels time of laying eggs of 26 weeks, 70% enter latter stage of laying eggs during 59 week age when 88%, 60 weeks when 85%, 69 weeks, supply Chinese medical extract drinking-water, Chinese medical extract is diluted with water to mass percent 4.6%; Lay eggs and continue 4 weeks latter stage (higher than 50%, lower than 70%.), after 50%, enter and eliminate or moult program.
In whole laying period, eggshell deliquescing lower than 0.021%, eggshell color and luster shoal lower than 0.027%.
Comparative trial, indigo plant is full of fowl industry and cultivates 8000, and as a control group, cultivate with traditional raising method, its each period data of laying eggs is:
19 week age saw egg, and 25 week age, laying rate reached 50%; 29 week age entered egg-laying peak (laying rate is greater than 90%), and 31 week age, the highest laying rate can reach more than 95%.Sustainable 21 weeks of the product courage of 31 weeks.After 54 week age, laying rate, lower than 80%, enters the latter stage laying rate of laying eggs and still can reach 50% to 70% after 58 weeks.Lay eggs and continue 2-3 week latter stage.In whole laying period, especially the later stage can find that egg has eggshell color to shoal and the phenomenon of eggshell deliquescing phenomenon, in whole laying period, eggshell deliquescing lower than 0.3%, eggshell color and luster shoal lower than 0.4%.List is compared
By above-mentioned contrast, can find, use Chinese medical extract of the present invention to carry out the method for feeding after seeing egg, can accelerate the time entering high term, extend the high duration in term, the phenomenon of eggshell deliquescing, lighter declines to a great extent simultaneously.
Egg production check experiment:
Choose each 200 plumages of the laying hen entering 26 weeks laying periods, be divided into two groups at random, one group of daily daily ration of feeding, as a control group.Chinese medical extract (Chinese medical extract is diluted with water to mass percent 1-2%) in another group feeding embodiment of the present invention 3, as experimental group.
Two groups of free choice feedings, freely drink water, illumination condition is identical, and rearing conditions is consistent, collects egg, every day entry feed intake, egg number and egg size during 14-15 in afternoon every day.
To sum up contrast, can find, feeding method of the present invention, especially at egg-laying peak, feed consumption is few, and laying rate is high, and the average counterpoise of egg size is high, is conducive to raiser's increasing both production and income.
Ovarian weight augmentation data compare
Select 40 laying hens in later stage laying period, be divided into two groups at random, often organize 20 (control group and experimental group), after entering later stage laying period, the diet feed of control group feeding tradition laying hen.(Chinese medical extract is diluted with water to mass percent 2-4% to experimental group feeding Chinese medical extract of the present invention; Meanwhile, add Chinese medical extract 3-5% in feed diet, improve the content of bone meal or conch meal to 4.8-5.2%, add sodium selenite 0.002%, the content of vitamin D increases to 0.04%.), cut open inspection, ovary weight of weighing (carries out cuing open inspection before first time choice experiment group feeding Chinese medical extract of the present invention, second time selects feeding to cut open inspection after 3 days, and third time selects feeding to cut open inspection after 8 days, selects for the 4th time feeding to cut open inspection after 14 days, each often group cuts open inspection 5, meter mean value).
By above-mentioned contrast, in the feeding the present invention in latter stage (lay eggs latter stage, ovary falls into a decline) that lays eggs, can effective stimulus ovarian function, lower ovary fall time.Namely can extend laying period, stimulate egg production, maintain ovarian function, eggshell deliquescing can be lowered, the occurrence probability that eggshell color shoals.
The corresponding feed that in the present invention, in embodiment, in experimental group, control group, egg-laying peak uses is as follows: (for unified experimental standard) corn 59.2%, wheat bran 2%, dregs of beans 22.5%, the dish dregs of rice 9.5%, calcium monohydrogen phosphate 1.3%, stone flour 1.2%, salt 0.3%, oil 3%, additive 1%.
The inventive method is simple, easy to use, promotes chicken fowl Development of Reproductive System, maintains genital system function-stable, extend laying period, keep egg quality of egg, avoid eggshell to shoal, the mechanism of action of Chinese medical extract of the present invention:
Ovary outer as adipose tissue, adrenal virtueization enzyme system also can release portion oestrogenic hormone, therefore, by medicine (particularly Chinese medicine), ovary is failed or oestrogenic hormone minimizing recovery is orderly or slow down decline rate.
The present invention, plays both sides of the street for monarch drug in a prescription with the leaf of bamboo, golden cypress, the root bark of tree peony, honeysuckle, Fructus Hordei Germinatus, madder, hairyvein agrimony, safflower, spina date seed, pyrola are ministerial drug, and Chinese yam, saline cistanche, Radix Codonopsis, dogwood, tortoise plastron are adjutant, and soybean is for making medicine.
Leaf of bamboo clearing heat and relieving fidgetness, promote the production of body fluid, diuresis, golden cypress heat-clearing and damp-drying drug, purging intense heat and detonicating, root bark of tree peony promoting blood circulation to remove blood stasis, play both sides of the street dispelling, collateral-activating, Li Shui, stimulate the menstrual flow, honeysuckle dispelling wind and heat from the body, its active ingredient cyanidenon stimulates oestrogenic hormone, Fructus Hordei Germinatus help digestion and in, madder activating blood to promote menstruation, hairyvein agrimony astringing to arrest bleeding, qi-restoratives, safflower activating blood to promote menstruation, spina date seed nourishes heart beneficial liver, calm the nerves, pyrola strengthening the bones and muscles, regulating menstruation, hemostasis, Chinese yam supplementing qi and nourishing yin, tonifying spleen lung kidney, saline cistanche benefiting essence-blood, relax bowel, Radix Codonopsis tonifying middle-Jiao and Qi, promote the production of body fluid, nourish blood, dogwood tonifies the liver and kidney, tortoise plastron consolidating channel for hemostasis, to nourish blood bushing, daizeol stimulates oestrogenic hormone.The present invention is to improve immunity of organisms simultaneously, and tonify the liver and kidney stimulation oestrogenic hormone, promotes hematopoiesis function, maintains the better state of genital system, and filling liver kidney, nourishing blood and invigorating qi reduce genital system diseases and then ensure eggshell color and luster.The amino acid powder added is commercially available prod, and index is total number of bacteria 5000/g, Escherichia coli: 30MPN/100g total amino acid content 80.9, essential amino acid/total amino acid content 36.1.Appropriate protein (makeup energy maintains ovarian function) is supplemented by amino acid powder.Later stage increases bone meal or conch meal, improves the calcium content of feed, strengthens calcium uptake by vitamin D, keeps eggshell hardness, adds in feed
sodium selenite, laying rate, incubation rate and young incubation rate can be improved to bird.
Claims (4)
1. a chicken-raising method for laying hen, is characterized in that,
A, Egg Production of Laying Hens open term: supply Chinese medical extract drinking-water, and Chinese medical extract is diluted with water to mass percent 0.5-1%;
B, Egg Production of Laying Hens height term: supply Chinese medical extract drinking-water, Chinese medical extract is diluted with water to mass percent 1-2%;
C, laying cycle of laying hens later stage: supply Chinese medical extract drinking-water, Chinese medical extract is diluted with water to mass percent 2-4%; Meanwhile, add Chinese medical extract 3-5% in feed diet, improve the content of bone meal or conch meal to 4.8-5.2%, add sodium selenite 0.001-0.002%, the content of vitamin D increases to 0.01-0.05%;
The component of described Chinese medical extract is:
The leaf of bamboo, golden cypress, each 60-80g of the root bark of tree peony, play both sides of the street, honeysuckle, Fructus Hordei Germinatus, madder, hairyvein agrimony, safflower, spina date seed, each 40-60g of pyrola, Chinese yam, saline cistanche, Radix Codonopsis, dogwood, each 30-50g of tortoise plastron, soybean 20-25g.
2. the chicken-raising method of described laying hen according to claim 1, it is characterized in that, the component of described Chinese medical extract is:
The leaf of bamboo, golden cypress, each 60-70g of the root bark of tree peony, play both sides of the street, honeysuckle, Fructus Hordei Germinatus, madder, hairyvein agrimony, safflower, spina date seed, each 40-50g of pyrola, Chinese yam, saline cistanche, Radix Codonopsis, dogwood, each 30-40g of tortoise plastron, soybean 20-22g.
3. the chicken-raising method of described laying hen according to claim 1, it is characterized in that, the component of described Chinese medical extract is:
The leaf of bamboo, golden cypress, each 70-80g of the root bark of tree peony, play both sides of the street, honeysuckle, Fructus Hordei Germinatus, madder, hairyvein agrimony, safflower, spina date seed, each 50-60g of pyrola, Chinese yam, saline cistanche, Radix Codonopsis, dogwood, each 40-50g of tortoise plastron, soybean 22-25g.
4., according to the chicken-raising method of the arbitrary described laying hen of claim 1-3, it is characterized in that, time prepared by Chinese medical extract,
After said components is mixed, with water extract method lixiviate three times, after three times leaching liquor merges, boiling obtains mixture of viscous form, adds CMC and flavouring; The mass ratio of CMC, flavouring is 2:1, the quality of CMC and flavouring and be the 2-3% of mixture of viscous form quality, pulvis is obtained after drying, pulvis is after ultraviolet irradiation is sterilized 10 seconds, add amino acid powder, the quality of the amino acid powder added is the 0.01-0.03% of pulvis quality, obtains Chinese medical extract after mixing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410572016.XA CN104322443A (en) | 2014-10-24 | 2014-10-24 | Chicken raising method of laying hens |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410572016.XA CN104322443A (en) | 2014-10-24 | 2014-10-24 | Chicken raising method of laying hens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104322443A true CN104322443A (en) | 2015-02-04 |
Family
ID=52397374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410572016.XA Pending CN104322443A (en) | 2014-10-24 | 2014-10-24 | Chicken raising method of laying hens |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104322443A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105876249A (en) * | 2016-04-25 | 2016-08-24 | 青岛奕奕和农牧科技有限公司 | Traditional Chinese medicine health-preserving immunization method for breeding laying hens |
| CN106172218A (en) * | 2016-07-27 | 2016-12-07 | 武夷山元生泰生物科技有限公司 | A kind of cultural method of lucid ganoderma chicken |
| CN107258672A (en) * | 2017-07-04 | 2017-10-20 | 界首市康泽家庭农场 | A kind of reed catkins chicken in egg-laying period cultural method |
| CN108902014A (en) * | 2018-06-01 | 2018-11-30 | 杨斌 | A kind of feeding method that laying hen whole process feeding herbal decoction is watered |
-
2014
- 2014-10-24 CN CN201410572016.XA patent/CN104322443A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105876249A (en) * | 2016-04-25 | 2016-08-24 | 青岛奕奕和农牧科技有限公司 | Traditional Chinese medicine health-preserving immunization method for breeding laying hens |
| CN106172218A (en) * | 2016-07-27 | 2016-12-07 | 武夷山元生泰生物科技有限公司 | A kind of cultural method of lucid ganoderma chicken |
| CN107258672A (en) * | 2017-07-04 | 2017-10-20 | 界首市康泽家庭农场 | A kind of reed catkins chicken in egg-laying period cultural method |
| CN108902014A (en) * | 2018-06-01 | 2018-11-30 | 杨斌 | A kind of feeding method that laying hen whole process feeding herbal decoction is watered |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103583927B (en) | Reserve sow mixed feed capable of increasing production performance of sow and preparation method | |
| CN103931908B (en) | Improve the feed of Egg Production of Laying Hens later stage production performance and eggshell quality | |
| CN102599367B (en) | Herbal compound premix for replacement layers | |
| CN1868302B (en) | Chinese herb medicine additive for chicken feed | |
| CN105475639A (en) | Ration for feeding beef cattle for producing snowflake beef and concentrate supplement formula | |
| CN101991020B (en) | Traditional Chinese medicine chicken feed and production method of black bone chicken egg with effects of regulating internal secretion of human body and removing spots and beautifying and protecting health | |
| CN101473900A (en) | Complete compound feed for weaning piglet | |
| CN106234825A (en) | A kind of laying period egg feedstuff | |
| CN106804982A (en) | Help and improve chicken and lay eggs the feed and preparation method thereof of quality | |
| CN104905027A (en) | Quail feed capable of enhancing immunity | |
| CN109479822A (en) | A kind of method for breeding of snowflake beef cattle | |
| CN104322443A (en) | Chicken raising method of laying hens | |
| CN104872066A (en) | Chicken breeding method | |
| CN104247894A (en) | Medium and large duck feed for limited feeding of cherry valley meat ducks | |
| CN106578612A (en) | Chinese herbal medicine containing special feed for meat chickens | |
| CN107484926A (en) | It is a kind of prevent the raw rotten body of fish into carp compound feed and its application | |
| CN104351545A (en) | Chinese herbal medicine nutritional feed for cultivating giant salamanders | |
| CN102613434A (en) | Pig feed additive and preparation as well as use method thereof | |
| CN104322889A (en) | Chicken raising method capable of preventing color of egg shells from becoming light | |
| CN105941319A (en) | A forced moulting method for laying hens | |
| CN104322888A (en) | Traditional Chinese medicine extract for farming laying hens | |
| CN109362963A (en) | A kind of lactating sow compound premixed feed and its preparation method and application improving weight of weaning litter | |
| CN102217715A (en) | Feed for Zuojia pheasants | |
| CN104770581A (en) | Feed for Hu sheep in lactation period | |
| CN104381200A (en) | Chicken raising method for maintaining eggshell quality |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150204 |
|
| WD01 | Invention patent application deemed withdrawn after publication |